Foreword

por Sandhaus, Robert A.
Publicado 2021

An analysis of the degree of concordance among international guidelines regarding alpha-1 antitrypsin deficiency

por Attaway, Amy, Majumdar, Uddalak, Sandhaus, Robert A, Nowacki, Amy S, Stoller, James K
Publicado 2019

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency

por Chorostowska-Wynimko, Joanna, Barrecheguren, Miriam, Ferrarotti, Ilaria, Greulich, Timm, Sandhaus, Robert A, Campos, Michael
Publicado 2020

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US

por Sandhaus, Robert, Strange, Charlie, Stone, Glenda, Runken, M Chris, Blanchette, Christopher M, Howden, Reuben
Publicado 2020

Improving the Lives of Patients with Alpha-1 Antitrypsin Deficiency

por Sandhaus, Robert A, Strange, Charlie, Zanichelli, Andrea, Skålvoll, Karen, Koczulla, Andreas Rembert, Stockley, Robert A
Publicado 2020

Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence

por Bai, Xiyuan, Schountz, Tony, Buckle, Ashley M., Talbert, Janet L., Sandhaus, Robert A., Chan, Edward D.
Publicado 2023

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVI...

por Herth, Felix J F, Sandhaus, Robert A, Turner, Alice M, Sucena, Maria, Welte, Tobias, Greulich, Timm
Publicado 2021

Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency

por Mayer, Annyce S, Stoller, James K, Vedal, Sverre, Ruttenber, A James, Strand, Matt, Sandhaus, Robert A, Newman, Lee S
Publicado 2006

Environmental, occupational, and genetic risk factors for alpha-1 antitrypsin deficiency.

por Sharp, Richard R, de Serres, Frederick, Newman, Lee, Sandhaus, Robert A, Walsh, John W, Hood, Ernie, Harry, G Jean
Publicado 2003

Clinical considerations in individuals with α(1)-antitrypsin PI*SZ genotype

por McElvaney, Gerard N., Sandhaus, Robert A., Miravitlles, Marc, Turino, Gerard M., Seersholm, Niels, Wencker, Marion, Stockley, Robert A.
Publicado 2020

Pharmacokinetic comparability of Prolastin(®)-C to Prolastin(® )in alpha(1)-antitrypsin deficiency: a randomized study

por Stocks, James M, Brantly, Mark L, Wang-Smith, Laurene, Campos, Michael A, Chapman, Kenneth R, Kueppers, Friedrich, Sandhaus, Robert A, Strange, Charlie, Turino, Gerard
Publicado 2010

Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity Against Non-tuberculous Mycobacteria

por Bai, Xiyuan, Bai, An, Honda, Jennifer R., Eichstaedt, Charles, Musheyev, Ariel, Feng, Zhihong, Huitt, Gwen, Harbeck, Ronald, Kosmider, Beata, Sandhaus, Robert A., Chan, Edward D.
Publicado 2019

Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19

por Bai, Xiyuan, Hippensteel, Joseph, Leavitt, Alida, Maloney, James P., Beckham, David, Garcia, Cindy, Li, Qing, Freed, Brian M., Ordway, Diane, Sandhaus, Robert A., Chan, Edward D.
Publicado 2021

Detection of alpha-1 antitrypsin deficiency: the past, present and future

por Brantly, Mark, Campos, Michael, Davis, Angela M., D’Armiento, Jeanine, Goodman, Kenneth, Hanna, Kathi, O’Day, Miriam, Queenan, John, Sandhaus, Robert, Stoller, James, Strange, Charlie, Teckman, Jeffrey, Wanner, Adam
Publicado 2020

Quantitative disease progression model of α‐1 proteinase inhibitor therapy on computed tomography lung density in patients with α‐1 antitrypsin deficiency

por Tortorici, Michael A., Rogers, James A., Vit, Oliver, Bexon, Martin, Sandhaus, Robert A., Burdon, Jonathan, Chorostowska‐Wynimko, Joanna, Thompson, Philip, Stocks, James, McElvaney, Noel G., Chapman, Kenneth R., Edelman, Jonathan M.
Publicado 2017

Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19

por Bai, Xiyuan, Buckle, Ashley M., Vladar, Eszter K., Janoff, Edward N., Khare, Reeti, Ordway, Diane, Beckham, David, Fornis, Lorelenn B., Majluf-Cruz, Abraham, Fugit, Randolph V., Freed, Brian M., Kim, Soohyun, Sandhaus, Robert A., Chan, Edward D.
Publicado 2022

Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19

por Bai, Xiyuan, Buckle, Ashley M., Vladar, Eszter K., Janoff, Edward N., Khare, Reeti, Ordway, Diane, Beckham, David, Fornis, Lorelenn B., Majluf-Cruz, Abraham, Fugit, Randolph V., Freed, Brian M., Kim, Soohyun, Sandhaus, Robert A., Chan, Edward D.
Publicado 2022

Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency

por Kim, Woo Jin, Wood, Alice M, Barker, Alan F, Brantly, Mark L, Campbell, Edward J, Eden, Edward, McElvaney, Gerard, Rennard, Stephen I, Sandhaus, Robert A, Stocks, James M, Stoller, James K, Strange, Charlie, Turino, Gerard, Silverman, Edwin K, Stockley, Robert A, DeMeo, Dawn L
Publicado 2012